chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1/14/15 - received HIB and PCV13 vaccines 1015 AM. Approximately 4PM, patient developed vomiting, went rigid and then limp requiring medical transport -> ER. Prior simple episode reported 10/23/14 with exposure to same vaccines.
Initial report received from a healthcare professional on 23 October 2012. A 23-year-old female patient, who has medical history of allergy to food (Bananas and Avocados) and whose concomitant medications were not reported, received a dose of FLUZONE ID vaccine (lot number: UT4464AA) intradermally in the left deltoid on 20 October 2012. On 22 October 2012, 2 days after vaccination, the patient experienced swelling on her collar bone (left side same as injection site). There was no redness or pain. Corrective medications and laboratory investigations were not reported. As of 23 October 2012, the patient had not recovered from the event. List of documents held by sender: none.
Patient received vaccine in late afternoon. Wife stated patient awoke next am with extreme lethargy, unable to dress/feed himself, began having mild trembling. Trembling has ceased, remains lethargic and unable to dress/feed self. Wife reported condition to physician, who agreed pt was more lethargic.
Received COVID vaccine on 1/7 in L arm and had sore arm for 1-2 days but no other symptoms for first 2 days. Then on 1/9, developed facial twitching (left side of face just above L cheek), which was sporadic (1-2 twitches/hr). This stopped 1/14. However, he has also noticed slight asymmetry with smile and has flattening of the right cheek compared to left.  Patient is a virology/vaccine researcher and works with SARS-COV-2, TB, chicken coronavirus, and environmental microbacteria. No fatigue, no other symptoms; frequently tested for COVID, all negative. No weakness, changes in sensation, changes in gait, or difficulty breathing/swallowing/speaking. No hx vaccine rxn, gets flu shot every year.
Injection site pain, tiredness, headache, muscle pain, chills, fever, injection site swelling, nausea, feeling unwell.  Took Tylenol for pain in arm. Drank a lot of fluids and slept most of Thursday 4/15 to  Friday 4/16.  Saturday 4/17 fever broke still had a dull headache , no nausea wasn't as weak. Felt better as the day went on.  Saturday evening  4/ 17 was back to feeling well.
Patient presents on 10/31/2009 with bilateral and symmetrical limb weakness as well as decreased deep tendon reflexes. LP performed on patient.
Feeling very weak; Headache; Felt awful; Terrible fever; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt awful), ASTHENIA (Feeling very weak), PYREXIA (Terrible fever) and HEADACHE (Headache) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced MALAISE (Felt awful) and PYREXIA (Terrible fever). On 06-May-2021, the patient experienced ASTHENIA (Feeling very weak) and HEADACHE (Headache). On 06-May-2021, HEADACHE (Headache) had resolved. At the time of the report, MALAISE (Felt awful), ASTHENIA (Feeling very weak) and PYREXIA (Terrible fever) outcome was unknown.            No concomitant medication provided. No treatment information provided.
11 year old patient received 1st dose of Pfizer vaccine: 30mcg/0.3mL.  NO adverse drug reaction has been observed. Nurse followed with patient.  Pt is stable, without any distress
This case was reported by a other health professional via call center representative and described the occurrence of shingles in a female patient who received SHINGRIX for prophylaxis. On 27th February 2019, the patient received SHINGRIX. On 27th February 2019, less than a day after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were received as follows: The age at vaccination was not reported. After vaccination with Shingrix they were diagnosed with the infection. The physician examined the patient same day post vaccination and diagnosed the shingles infection. No additional details provided.
dizziness, fall  Fall, initial encounter  Skin abrasion  Contusion of right back wall of thorax, initial encounter  Acute hip pain, left  Dizziness  Dehydration
Pericarditis; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) Dose 2 via an unspecified route of administration, administered in the right arm on 12Apr2021 at 16:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. There were no medical history or concomitant medications. The patient previously received the first dose of BNT162b2 on 12Mar2021 (Lot Number: EN6208) via an unspecified route of administration in the right arm for COVID-19 immunisation. The patient experienced pericarditis on 28Apr2021, for which he was hospitalized from 29Apr2021 to 01May2021. The patient stated that on 12Apr2021, he had his second shot of the vaccine. The patient stated he is very thankful for the vaccine and he was over the moon to receive it. The patient stated on 29Apr2021, he ended up in the hospital and he had pericarditis, an inflammation of the lining around his heart. The patient stated when it first happened, it was a feeling like indigestion at night and when he went to bed, he had sharp pains in his chest. The patient stated at 2:00a.m. he started looking up symptoms of a heart attack and by 3:00a.m., he woke his husband up, who is a doctor, and he took him to the hospital at 4:00a.m. The patient stated his cardiologist told him it may be a side effect of the vaccine. The patient stated he has never had any issues with his heart. The patient stated they did complete research of his heart and said it was in great shape, it was weird why the lining swelled up. There were no relevant tests reported. The patient recovered from the event on 01May2021.
2 episodes of sleep apnea at 2 and 4am.  Breathing alarm sounded after 20 seconds of no breathing.  No false alarms or previous episodes prior to yesterday.
sinus infection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 15Mar2021 11:00 (Batch/Lot number: unknown) at the age of 60 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "known allergies: Penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: SINUSITIS (non-serious), outcome "unknown", described as "sinus infection".  Additional information: The facility type vaccine was pharmacy or drug store. Patient did not receive any other vaccine in four weeks.  Patient did not have covid prior to vaccination. Patient did not have covid post vaccination. Patient had a sinus infection after last shot.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
For the patient's second dose, he received undiluted pediatric Pfizer (PEDS) vaccine (0.2 mL of undiluted vaccine). Patient's father was contacted on the morning of 2/11/22 which is when the incident was discovered. When asked how the patient was feeling, the father reported he "felt good" and that he was "fine," disclosing no concerns at this time. Patient's father was instructed to contact pharmacy with any future questions or concerns related to systemic side effects.
Pt recvd vax 10MAR93 & 3 wks p/vax devel papillitis, optic neuritis & blindness; pt was hospitalized;
increased fibromyalgia; lack of endurance, decreased exercise; This spontaneous case was reported by a consumer and describes the occurrence of FIBROMYALGIA (increased fibromyalgia) and EXERCISE TOLERANCE DECREASED (lack of endurance, decreased exercise) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced FIBROMYALGIA (increased fibromyalgia) and EXERCISE TOLERANCE DECREASED (lack of endurance, decreased exercise). At the time of the report, FIBROMYALGIA (increased fibromyalgia) had not resolved and EXERCISE TOLERANCE DECREASED (lack of endurance, decreased exercise) outcome was unknown.            She had severe lack of endurance  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, the patient history of Fibromyalgia is a strong confounder.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, the patient history of Fibromyalgia is a strong confounder.
This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown age. There was no information about concurrent condition and historical medication. On 22-JUN-2016, the patients were vaccinated with improperly stored ZOSTAVAX, lot no. M001747/expiration date 07-APR-2017. No adverse event was reported. Temperature was 17.6 F and time frame was 4 hours, 15 minutes. There was no previous temperature excursion and call was not because of data logger. The outcome of the event was unknown. Additional information has been requested.
p/vax pt exp rt upper arm 3'' circular pattern acneiform rash w/clear center; actual site is hyperpigmented
Dose given was 3 days expired at time of vaccination. Dose was given 10/3/2022, vial was manufactured in 10/21 and was considered expired as of 9/30/2022. Family was notified roughly 30 minutes after vaccination occurred, education was provided regarding Covid vaccination. Repeat dose suggested per Pfizer. Client had no reactions, no adverse events reported. Received repeat dose on 10/13/2022.
1. Soreness around injection site within 3 hrs. Still sore. 6 days later. 2.  Swollen  and sore lymphnodes  in the left armpit . Started day after injection.  Still sore 6 days later but soreness is lessening.   3. Day 2 after injection sore tail bone for no reason.  Day 6 soreness  almost gone.
received expired vaccines; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received expired vaccines) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A, 12L20A and 101M20) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (received expired vaccines). On 24-Sep-2021, EXPIRED PRODUCT ADMINISTERED (received expired vaccines) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided. No treatment medications provided.
Currently 25 weeks pregnant, got the J & J vaccine Friday 10/22 @ 2:15pm. Due date January 31st 2022. At 10:15pm I started to feel very very cold and start shaking and couldn't stop my shakes. I enter the house and started to talk with my husband, he couldn't understand what I was saying and I did not realized I was not speaking English. He told me what I felt in English and he put me to sit on the couch and cover me with 2 blankets and gave me tea to warm up. Took me one hour to finally warm up and be able to take the blankets off and change in pajamas. After that went to bed and monitor my fever and got up to 100.1 F. all night I have fever, chills and sweat very much. That night took Tylenol. I woke up the morning 10/23 still not feeling 100% good and took another Tylenol. That day still not feeling 100% myself so I took another Tylenol in the evening. Next day, 10/24 finally much better and I have not been taking any medication.
Patient received his first MCV4,and HPV on 8/27/2020. He broke out in a red, raised, itchy rash all over his body that lasted 5 days.  No treatment, resolved on it's own. Mom didn't report until 2 weeks later at her appointment.
CLIENT HAD REACTION AT 12 MONTHS OF AGE. PARENTS TOOK CHILD TO ER, BECAUSE SHE BECAME LETHARGIC AFTER DTAP,HIB,POLIO,HEPB,MMR AND VARICELLA,AT ANOTHER CLINIC. THE PARENTS DID NOT TELL US THIS WHEN THEY PRESENTED THE CHILD FOR VACCINES ON 7/11/2007.  BUT THE MOTHER CHOSE TO ONLY GET ONE VACCINE AT A TIME AT THIS VISIT.  THE CHILD HAD DTAP ON 7/11/2007 AND LEFT THE HEALTH DEPT. WITH DRY HEAVES,PALE, AND THE MOTHER REPORTED THAT WHEN THEY LEFT IN THE CAR, THE CHILDS "EYES ROLLED BACK",AND THAT "THE CHILD WAS EXTREMELY SLEEPY" , THEN PROCEEDED TO CALL US.  THE CHILD HAD FELL ASLEEP, AND WAS BREATHING WITH OUT DIFFICULTY. INSTRUCTED TO WATCH CHILD FOR NEXT 48 HOURS, AND THAT I WOULD CALL TO CHECK ON THE CHILD.
Patient felt lightheaded and increased respiration, taken to med bay. Vitals stable (BP 110/76, HR72, RR22), states previous vasovagal reaction to vaccines. Given crackers and breathing relaxed. Patient left in stable condition
After first dose 21 days prior, pt reported some tingling in mouth. After this second dose pt developed tongue/throat tingling, itching, clearing throat, anxiety, and diaphoresis. Pt given Benadryl and Epipen and was sent to ED.
I believe I developed pericarditis from the second shot. Got COVID-19 in Feb 2020 and got my second shot May 5th, 2021 and within three weeks I had persistent and inexplicable chest pain and shortness of breath that sent me to the ER where they discovered an abnormality in my EKG. The doctor's diagnosis was pericarditis likely due to some kind of viral infection. No other cardiovascular issues, risks, or prior events. It went away shortly after but has come back this week. I don't have healthcare here in NY until Oct 1st 2021 so as soon as I can get in to see a doctor I will seek further treatment.
Mom noticed when she picked her up from daycare left arm swollen at site of injection down to elbow approx area size 3x6.
chills, fever, sore throat, cough, muscle aches since vax (6 days duration);
Increased Heart Rate - 90-100 BPM; Chills; Fever - Temperature of 101.5G; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Increased Heart Rate - 90-100 BPM), CHILLS (Chills) and PYREXIA (Fever - Temperature of 101.5G) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 030L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced TACHYCARDIA (Increased Heart Rate - 90-100 BPM), CHILLS (Chills) and PYREXIA (Fever - Temperature of 101.5G). At the time of the report, TACHYCARDIA (Increased Heart Rate - 90-100 BPM), CHILLS (Chills) and PYREXIA (Fever - Temperature of 101.5G) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Body temperature: high (High) 101.5.. On 03-Mar-2021, Heart rate: high (High) 90-100 BPM..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information not provided. List of concomitant medication were not given.
Dental work. 05/18/2011. Got cankers at inj points, jaw locked up. Still locked. Related to tetanus vac?
This spontaneous report as received from a registered nurse refers to an 18 year old female patient. The patient had no concomitant medication, no pertinent medical history and drug reaction/allergies. On 28-MAY-2013 the patient was vaccinated with her first dose of GARDASIL (lot # H021346, Exp date 01-OCT-2015) 0.5 ml, intramuscularly, and on 30-JUL-2013 the patient received her second dose of GARDASIL (Lot # unspecified) 0.5 ml, intramuscularly in right arm. In July 2013, the patient experienced hip and leg tightness and pain (both legs) after receiving her second dose of GARDASIL on 30-JUL-2013. The patient was also experiencing numbness of her feet while walking, and a sensation of "restless" legs. Patient sought medical attention by phone call to clinic by patient's mother. No treatment was given for the event and no lab diagnostics studies performed. The outcome of the patient was reported as not recovered/not resolved. Additional information is not expected.
Patient stated he did not feel good about 3-4 minutes after the injection, sat on the floor and a few moments later he lost consciousness and began to have dyskinetic movements for a period of 3-4 minutes.  Patient then regain consciousness and stated that he felt like he was having a seizure.  He was alert to person and place and knew that he had just gotten a vaccine.   He was given some apple juice and blood pressure was taken 5-10 minutes after episode.  Patient stated he felt ok and was able to leave office on his own, his mother was waiting in the car and drove him home.
On 5.7.2021, the skin on my arms and neck started itching and burning. Hives began to appear all over my upper body and face. I was exercising when this happened. Then my face started to swell. The same thing happened on 5.10.2021, only with more swelling and some difficulty catching a deep breath. I figured out the laundry detergent used on my work-out towels was the culprit; however, I have been using this detergent for 10+ years. I wonder if the immune response triggered by the vaccine also triggered an allergy to this detergent.
Gave pediatric/adolescent dose of Hepatitis A instead of adult dose. Dr notified at 16:04, 3/31/09.
Cellulitis left arm. Immunizations given on 03/20/2002. On 03/22/2002 mom calle dreported left arm upper swollen 2x normal size. Swollen down to wrist. Temp 102deg. F. Arm red, slightly indurated, warm and swollen.
A 21-month old male toddler (NP) experienced an injection site rash and fever after receiving RabAvert. The patient was administered 1 dose of RabAvert 1 ml injection and 1 dose of human recombinant immune globulin (HRIG) by injection on 25 Sep 03. The toddler has a history of rashes that have occurred post vaccination and also without medication administered.   On 25 Sep 03 the toddler was discovered by his mother standing over a bat but was not bitten. He was taken to the pediatric emergency department (ER) on that day and an injection of RabAvert and HRIG were administered by injection in his thighs. The child developed a rash consisting of red dots surrounding the injection site of both thighs in a circular pattern. The rash on one thigh was worse than the other one and it was not known by the ER staff which medication went into which thigh. The toddler also felt warm for 24 hours and the fever was treated with Tylenol. The fever resolved and the rash has improved spontaneously without treatment. The bat was tested and was negative for rabies  The events are considered possibly related to the RabAvert and the HRIG.
Patient presented to clinic and registered as 18 y/o for Janssen vaccine. Patient presented school ID, stated she did not have her drivers license. I scanned ID in chart and verified all demographic information including DOB. Patient stated all information was correct and LPN staff, LPN who was in orientation with FT clinic staff LPN, Another LPN. They were both in the room with me from the start of the visit. Emergency Use Authorization and VAERS V-SAFE Fact Sheet reviewed with patient. Patient denied any questions. Patient reported allergy to eggs. Consulted with pharmacist, Matengy and Janssen Manufacturer hotline to ensure that vaccine does not contain egg products which it does not contain any egg products. This took about 40 mins to do these consultations and research. While I was doing the research the patient kept asking if we can hurry and get the vaccine so she can leave and go to work. LPN's nd I kept reassuring patient that I have to make sure of her safety with getting this vaccine by making sure it does not contain eggs and to be patient.  Also, called mom who verified that patient's only allergy is to eggs. Mom said yes she's only allergic to eggs and that patient has done alot of research and she knows all the risks. Discussed with patient the risks of rare blood clots in her age group 18-50 years old. Patient said that she is well aware of the research as her mom is a dentist and all of her family have gotten the Janssen and she wants to get that one as well. She also stated that her PCP told her to come here and get the Janssen vaccine because they don't have it at the office. After all information discuseed LPN gave her the vaccine and LPN wrote the information on the covid vaccination card including her DOB and I sgned it. After getting the vaccine I gave the patient her visit summary and the card. As she was walking out the door to the observation area she looked at the card and said "Can you change this? I was born in 2003." I replied that is what you told us and that is what is in the system and she said I'm sorry it is 2003. So I changed the DOB in the system and it made her 17y/o, not 18. The Janssen vaccine is approved for 18 years and older. I immediately asked the patient to call her mom for me so that I can talk to her. She called mom I informed her that she was registered as 18 y/o and mom said "Oh that's okay. I don't mind that she got the vaccine. As long as she will get something saying she got the vaccine so that she can go to school." I explained to her that the vaccine is not approved for under 18 y/o. She said "I'm ok with that. I won't say anything. You can let whoever know so that if they want to put her in a trial or something I'm ok with that too." I told her I would be writing a safety report and I would let management know. Patient did not experience any adverse effects and left the clinic. LPN witnessed this conversation. I called SPM, who is covering for my manager today. SPM stated to complete a Patient Safety Event and VAERS report. Called collaborating MD Dr. and left a message to call me back.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 28-NOV-2015 at time- 18:39, the patient was vaccinated with improperly stored RECOMBIVAX HB with lot number: L016427 (expiry date, dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse effects were reported. The high temperature and low temperature at which the product was stored were 2.3 and 1.8 (units unspecified) respectively. There were no product quality complaints (PQC) involved. This is one of the several reports from the same reporter. Additional information has been requested.